Literature DB >> 21798218

New horizons for stem cell therapy in liver disease.

Stuart J Forbes1, Philip N Newsome.   

Abstract

There is an increasing range of potential applications of stem cells in liver diseases, with many clinical studies already undertaken. We identify four of the main areas which we propose stem cell therapy could be a realistic aim for in the future: (1) to improve regeneration and reduce scarring in liver cirrhosis by modulating the liver's own regenerative processes, (2) to down-regulate immune mediated liver damage, (3) supplying hepatocyte-like cells (HLCs) derived from stem cells for use in extracorporeal bio-artificial liver machines, and (4) to use stem cell derived HLCs for cell transplantation to supplement or replace hepatocyte function.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21798218     DOI: 10.1016/j.jhep.2011.06.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  31 in total

1.  Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives.

Authors:  Guido Carpino; Eugenio Gaudio
Journal:  Stem Cell Investig       Date:  2016-12-09

Review 2.  The fetal liver as cell source for the regenerative medicine of liver and pancreas.

Authors:  Rossella Semeraro; Vincenzo Cardinale; Guido Carpino; Raffaele Gentile; Cristina Napoli; Rosanna Venere; Manuela Gatto; Roberto Brunelli; Eugenio Gaudio; Domenico Alvaro
Journal:  Ann Transl Med       Date:  2013-07

Review 3.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

Review 4.  Cell therapy in chronic liver disease.

Authors:  Clara T Nicolas; Yujia Wang; Scott L Nyberg
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

5.  Regression modeling to inform cell incorporation into therapies for craniosynostosis.

Authors:  James Cray; Gregory M Cooper
Journal:  J Craniofac Surg       Date:  2013-01       Impact factor: 1.046

Review 6.  Concise review: clinical programs of stem cell therapies for liver and pancreas.

Authors:  Giacomo Lanzoni; Tsunekazu Oikawa; Yunfang Wang; Cai-Bin Cui; Guido Carpino; Vincenzo Cardinale; David Gerber; Mara Gabriel; Juan Dominguez-Bendala; Mark E Furth; Eugenio Gaudio; Domenico Alvaro; Luca Inverardi; Lola M Reid
Journal:  Stem Cells       Date:  2013-10       Impact factor: 6.277

Review 7.  Virus-related liver cirrhosis: molecular basis and therapeutic options.

Authors:  Ji Lin; Jian-Feng Wu; Qi Zhang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

8.  A case report of congenital glycogen storage liver cirrhosis treated with bone marrow derived stem cells.

Authors:  Terek W Wehbe; Nassim H Abi Chahine; Abdul-Rahman A Annous; Mohammad A Ferri; Robert C Boulous; Majid F El-Mestrah
Journal:  Stem Cell Investig       Date:  2017-09-07

Review 9.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

10.  mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.

Authors:  Jingsong Cao; Minjung Choi; Eleonora Guadagnin; Maud Soty; Marine Silva; Vincent Verzieux; Edward Weisser; Arianna Markel; Jenny Zhuo; Shi Liang; Ling Yin; Andrea Frassetto; Anne-Renee Graham; Kristine Burke; Tatiana Ketova; Cosmin Mihai; Zach Zalinger; Becca Levy; Gilles Besin; Meredith Wolfrom; Barbara Tran; Christopher Tunkey; Erik Owen; Joe Sarkis; Athanasios Dousis; Vladimir Presnyak; Christopher Pepin; Wei Zheng; Lei Ci; Marjie Hard; Edward Miracco; Lisa Rice; Vi Nguyen; Mike Zimmer; Uma Rajarajacholan; Patrick F Finn; Gilles Mithieux; Fabienne Rajas; Paolo G V Martini; Paloma H Giangrande
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.